Dental anxiety
Conditions
Interventions
Routine medical group:no
Low-dose intervention group:Dexmedetomidine hydrochloride nasal spray
High-dose intervention group:Dexmedetomidine hydrochloride nasal spray
Sponsors
Stomatological Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. 18 years = age <70 years; 2. Patient ASA scores I to II; 3. Low risk of airway obstruction (Mallampati score I to II); 4. Dental phobia patients (MDAS =12 points); 5. Patients with implant surgery time <90min; 6. Willing to participate in this study and to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Preoperative patients showed active cooperation, without anxiety or blood pressure> 180 / 100mmHg; 2. Patients not suitable for nasal spray administration, such as nasal congestion, severe rhinitis, nasal deformity, etc; 3. History of cerebral palsy, autism or other mental illness, using psychiatric medication; 4. Recent alcohol consumption, taking other drugs, especially selective a 2-adrenoceptor agonists or antagonists, sedative hypnotics, amphotericin B, opioid analgesics; 5. Patients with a known past medical history of myocardial infarction, unstable angina pectoris, severe arrhythmia, and cardiac insufficiency; 6. Known allergy to drugs or other ingredients in the drug; 7. Can not cooperate with the study for any reason;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dental Anxiety Score;Adverse reactions;Sedation Score;Visual Analogue Score;Discharge Score;Basic vital signs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Satisfaction Survey;Doctor Satisfaction Survey;Basic patient information; | — |
Countries
China
Contacts
Public ContactYujia Wu
Stomatological Hospital of Chongqing Medical University
Outcome results
None listed